Literature DB >> 22189837

Posterior reversible encephalopathy syndrome (PRES): electroencephalographic findings and seizure patterns.

Oliver Kastrup1, Markus Gerwig, Markus Frings, Hans-Christoph Diener.   

Abstract

To better describe seizure type, frequency, and electroencephalographic (EEG) findings in posterior reversible encephalopathy syndrome (PRES) and correlate these data with clinical and magnetic resonance imaging (MRI) data, we retrospectively assessed medical charts and EEG studies of patients with PRES treated between 2004 and 2011. Data collected included patients' underlying pathology, lesion distribution by MRI, seizure type and frequency, EEG pathologic background activity, focal pathology, and epileptogenic activity. Thirty-eight of 49 adults with PRES suffered from seizures; 17 underwent EEG and were included in the analysis. Perpetuating factors were similar to those reported in the literature. In 15 of 17 patients, MRI showed widespread involvement rather than purely occipital lesions. Nine patients had subcortical and cortical involvement. Seizures were single short grand mal (GM) in 11, serial GM in 2, recurrent GM in 2, and additional focal seizures in 2. No seizures were noted beyond the first day. After discontinuation of antiepileptic medication, no patients experienced seizure recurrence during 6-month follow-up. EEG showed diffuse theta/delta slowing in 13 patients and epileptogenic activity with focal sharp-wave and periodic lateralizing epileptiform discharges in 2 patients. Seizures in PRES are most commonly single GM and are usually of limited duration. EEG shows variable theta/delta slowing. Focal EEG pathology is seen in patients with focal seizures. Seizures occur early after disease onset and terminate spontaneously or under therapy during the first 24 h. Seizure recurrence beyond 24 h and chronic epilepsy were not seen. Seizures in PRES are frequent but appear to be uncomplicated and do not herald worse prognosis. EEG is helpful in evaluating the degree of encephalopathy and monitoring epileptic activity. Long-term antiepileptic medication does not appear to be warranted.

Entities:  

Mesh:

Year:  2011        PMID: 22189837     DOI: 10.1007/s00415-011-6362-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  16 in total

1.  Reversible encephalopathy associated with tacrolimus in pediatric renal transplants.

Authors:  P Parvex; M Pinsk; L E Bell; A M O'Gorman; Y G Patenaude; I R Gupta
Journal:  Pediatr Nephrol       Date:  2001-07       Impact factor: 3.714

2.  Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions.

Authors:  S O Casey; R C Sampaio; E Michel; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

3.  Epilepsy after neuroimaging normalization in a woman with tacrolimus-related posterior reversible encephalopathy syndrome.

Authors:  Mariella Baldini; Emanuele Bartolini; Sara Gori; Enrica Bonanni; Mirco Cosottini; Alfonso Iudice; Luigi Murri
Journal:  Epilepsy Behav       Date:  2010-02-18       Impact factor: 2.937

4.  Electroencephalographic (EEG) findings in posterior reversible encephalopathy associated with immunosuppressants.

Authors:  Jun Natsume; Ayako Sofue; Akio Yamada; Koji Kato
Journal:  J Child Neurol       Date:  2006-07       Impact factor: 1.987

Review 5.  Posterior reversible encephalopathy syndrome in intensive care medicine.

Authors:  Giuseppe Servillo; Francesca Bifulco; Edoardo De Robertis; Ornella Piazza; Pasquale Striano; Fabio Tortora; Salvatore Striano; Rosalba Tufano
Journal:  Intensive Care Med       Date:  2006-11-21       Impact factor: 17.440

6.  The reversible posterior cerebral edema syndrome.

Authors:  W P Dillon; H Rowley
Journal:  AJNR Am J Neuroradiol       Date:  1998-03       Impact factor: 3.825

7.  Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation.

Authors:  F Trullemans; F Grignard; B Van Camp; R Schots
Journal:  Eur J Haematol       Date:  2001-08       Impact factor: 2.997

8.  Posterior reversible encephalopathy syndrome due to severe hypercalcemia.

Authors:  O Kastrup; M Maschke; I Wanke; H C Diener
Journal:  J Neurol       Date:  2002-11       Impact factor: 4.849

9.  Development of chronic epilepsy after recurrent episodes of posterior reversible encephalopathy syndrome associated with periodic lateralized epileptiform discharges.

Authors:  Virginia Skiba; Mill Etienne; Joseph A Miller
Journal:  Seizure       Date:  2010-11-05       Impact factor: 3.184

10.  Periodic lateralized epileptiform discharges: an initial electrographic pattern in reversible posterior leukoencephalopathy syndrome.

Authors:  Archit Bhatt; Muhammad U Farooq; Shaila Bhatt; Arshad Majid; Mounzer Y Kassab
Journal:  Neurol Neurochir Pol       Date:  2008 Jan-Feb       Impact factor: 1.621

View more
  29 in total

1.  PRES-ing for Answers About Long-Term Seizure Risk in Patients With Posterior Reversible Encephalopathy Syndrome.

Authors:  David Spencer
Journal:  Epilepsy Curr       Date:  2015 Nov-Dec       Impact factor: 7.500

2.  Benign reversible encephalopathy syndrome after bevacizumab therapy for metastatic ovarian cancer.

Authors:  R Sawaya; W Radwan; S Hammoud
Journal:  Med Oncol       Date:  2014-01-03       Impact factor: 3.064

3.  The importance of neurophysiological assessment in posterior reversible encephalopathy syndrome: a case report of an eclamptic woman.

Authors:  S Maccora; C M Ministeri; R Fabbri; P G Fabbri
Journal:  Neurol Sci       Date:  2013-06-07       Impact factor: 3.307

4.  Posterior Reversible Encephalopathy Syndrome in Patients With Cancer.

Authors:  Samuel Singer; Christian Grommes; Anne S Reiner; Marc K Rosenblum; Lisa M DeAngelis
Journal:  Oncologist       Date:  2015-06-01

Review 5.  Takayasu's arteritis and posterior reversible encephalopathy syndrome: a case-based review.

Authors:  Carlos Rodrigo Camara-Lemarroy; Jackeline Grace Lara-Campos; Eduardo Perez-Contreras; René Rodríguez-Gutiérrez; Dionicio Angel Galarza-Delgado
Journal:  Clin Rheumatol       Date:  2013-01-06       Impact factor: 2.980

6.  Influence of Tacrolimus on Depressive-Like Behavior in Diabetic Rats Through Brain-Derived Neurotrophic Factor Regulation in the Hippocampus.

Authors:  Yoo Jin Shin; Yeon Tae Chun; Sun Woo Lim; Kang Luo; Yi Quan; Sheng Cui; Eun Jeong Ko; Byung Ha Chung; Jiyeong Lee; Seongno Hong; Mun Yong Lee; Hee Gyoo Kang; Chul Woo Yang
Journal:  Neurotox Res       Date:  2019-06-14       Impact factor: 3.911

7.  Neurological Complications after Renal Transplantation: A Retrospective Clinical Study.

Authors:  Nilgün Cengiz; Zelal Adibelli; Yarkın Kamil Yakupoğlu; Hande Türker
Journal:  Noro Psikiyatr Ars       Date:  2015-12-01       Impact factor: 1.339

8.  Isolated pontine involvement in posterior reversible encephalopathy syndrome with coincidental acute ischaemic stroke.

Authors:  Indunil Deepthi Kumara Wijenayake Galagamage; Anjali Sujith; Ajith Kumara Kiringodage
Journal:  BMJ Case Rep       Date:  2019-04-16

9.  Hypertension, seizures, and epilepsy: a review on pathophysiology and management.

Authors:  Sara Gasparini; Edoardo Ferlazzo; Chiara Sueri; Vittoria Cianci; Michele Ascoli; Salvatore M Cavalli; Ettore Beghi; Vincenzo Belcastro; Amedeo Bianchi; Paolo Benna; Roberto Cantello; Domenico Consoli; Fabrizio A De Falco; Giancarlo Di Gennaro; Antonio Gambardella; Gian Luigi Gigli; Alfonso Iudice; Angelo Labate; Roberto Michelucci; Maurizio Paciaroni; Pasquale Palumbo; Alberto Primavera; Ferdinando Sartucci; Pasquale Striano; Flavio Villani; Emilio Russo; Giovambattista De Sarro; Umberto Aguglia
Journal:  Neurol Sci       Date:  2019-05-04       Impact factor: 3.307

Review 10.  Chemotherapy-Related Neurotoxicity.

Authors:  Sophie Taillibert; Emilie Le Rhun; Marc C Chamberlain
Journal:  Curr Neurol Neurosci Rep       Date:  2016-09       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.